Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillipp Hartmann

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|February 22, 2023
IgY antibodies against cytolysin reduce ethanol-induced liver disease in miceNoemí Cabré, Phillipp Hartmann, Cristina Llorente, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 7, 2025
Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose bingeGreta Karoline Viebahn, Amit Khurana, Linton Freund, et al.
Obesity Pillars|April 15, 2025
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025Jennifer Panganiban, Mohit Kehar, Samar H Ibrahim, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2026
Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver diseaseHenriette Kreimeyer, Marcos F Fondevila, Aenne Harberts, et al.
Hepatology (Baltimore, Md.)|February 15, 2013
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in micePhillipp Hartmann, Peng Chen, Hui J Wang, et al.
Cell Host & Microbe|October 18, 2025
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial TranslocationLirui Wang, Derrick E Fouts, Peter Stärkel, et al.
Cell Host & Microbe|February 12, 2016
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial TranslocationLirui Wang, Derrick E Fouts, Peter Stärkel, et al.
Hepatology Communications|January 27, 2023
Malassezia restricta promotes alcohol-induced liver injurySuling Zeng, Phillipp Hartmann, Minji Park, et al.
ACS Pharmacology & Translational Science|March 20, 2025
<i>d</i> <sub>4</sub>-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing SteatohepatitisAleksandra Leszczynska, Thibault Alle, Benedikt Kaufmann, et al.
Alcohol, Clinical & Experimental Research|March 5, 2023
Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in miceTetsuya Kouno, Suling Zeng, Yanhan Wang, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|February 22, 2023
IgY antibodies against cytolysin reduce ethanol-induced liver disease in miceNoemí Cabré, Phillipp Hartmann, Cristina Llorente, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 7, 2025
Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose bingeGreta Karoline Viebahn, Amit Khurana, Linton Freund, et al.
Obesity Pillars|April 15, 2025
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025Jennifer Panganiban, Mohit Kehar, Samar H Ibrahim, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2026
Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver diseaseHenriette Kreimeyer, Marcos F Fondevila, Aenne Harberts, et al.
Hepatology (Baltimore, Md.)|February 15, 2013
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in micePhillipp Hartmann, Peng Chen, Hui J Wang, et al.
Cell Host & Microbe|October 18, 2025
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial TranslocationLirui Wang, Derrick E Fouts, Peter Stärkel, et al.
Cell Host & Microbe|February 12, 2016
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial TranslocationLirui Wang, Derrick E Fouts, Peter Stärkel, et al.
Hepatology Communications|January 27, 2023
Malassezia restricta promotes alcohol-induced liver injurySuling Zeng, Phillipp Hartmann, Minji Park, et al.
ACS Pharmacology & Translational Science|March 20, 2025
<i>d</i> <sub>4</sub>-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing SteatohepatitisAleksandra Leszczynska, Thibault Alle, Benedikt Kaufmann, et al.
Alcohol, Clinical & Experimental Research|March 5, 2023
Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in miceTetsuya Kouno, Suling Zeng, Yanhan Wang, et al.
Pageof 7